Skip to main content
Erwin Gelfand, MD, Pediatrics, Denver, CO

ErwinWGelfandMD

Pediatrics • Denver, CO

Professor of Pediatrics, University Colorado

Join to view full profile

Dr. Gelfand is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Gelfand's full profile

Already have an account?

  • Office

    1400 Jackson St
    Denver, CO 80206
    Phone+1 303-388-4461
    Fax+1 303-270-2174

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1969 - 1971
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterInternship, Pediatrics, 1968 - 1969
  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1966

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 1987 - 2025
  • Pediatrics
    American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • CORE Magazine Castle Connolly, 2006
  • Elected Member The American Society for Clinical Investigation, 1980

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • The 35th Annual National Jewish Health Pulmonary and Allergy Update at Keystone 
    National Jewish Health, Keystone, Colorado - 2/6/2013

Press Mentions

  • Blockade of Histamine Receptors Suppresses Intestinal Anaphylaxis in Peanut Allergy
    Blockade of Histamine Receptors Suppresses Intestinal Anaphylaxis in Peanut AllergyNovember 15th, 2016
  • Was the Doctor Right About Your Child's Asthma Diagnosis?
    Was the Doctor Right About Your Child's Asthma Diagnosis?May 19th, 2016
  • Teva Announces FDA Approval of ProAir RespiClick® (Albuterol Sulfate) Inhalation Powder for Patients with Pediatric Asthma
    Teva Announces FDA Approval of ProAir RespiClick® (Albuterol Sulfate) Inhalation Powder for Patients with Pediatric AsthmaMay 17th, 2016
  • Join now to see all

Grant Support

  • Administrative Core ANational Heart, Lung, And Blood Institute2010–2011
  • Naturally Occurring T Regulatory Cells Control Airway HyperresponsivenessNational Institute Of Allergy And Infectious Diseases2009–2011
  • Ltb4-Blt1 Interactions In The Pathogenesis Of Allergic Airway DiseaseNational Heart, Lung, And Blood Institute2007–2011
  • Inflammation, Airways Reactivity And AsthmaNational Heart, Lung, And Blood Institute2001–2011
  • Antenatal Dietary Supplementation Is A Risk Factor For Infant Atopy Through EpigeEunice Kennedy Shriver National Institute Of Child Health &Human Development2009–2010
  • Naturally Occurring T Regulatory Cells Control Airway HyperresponsivenessNational Institute Of Allergy And Infectious Diseases2008
  • Administrative CoreNational Heart, Lung, And Blood Institute2007
  • Age-Dependent Increases In Airway Responsiveness By RSVNational Heart, Lung, And Blood Institute2004–2007
  • Role Of T Lymphocytes In Airway HyperresponsivenessNational Heart, Lung, And Blood Institute1996–2005
  • Training Program In Pediatric ImmumologyNational Institute Of Allergy And Infectious Diseases2002–2004
  • MEKK2 Regulation Of MAST Cell/T Cell Cytokine ProductionNational Institute Of Allergy And Infectious Diseases2003
  • RSV Enhances Sensitization And Airway ResponsivenessNational Heart, Lung, And Blood Institute1999–2002
  • Regulation Of MAST Cell Cytokine ProductionNational Institute Of Allergy And Infectious Diseases1998–2002
  • Mechanisms Of Steroid Reduction In IVIG Treated AsthmaNational Institute Of Allergy And Infectious Diseases1996–1997
  • Humoral And Cell-Mediated Immunity In Development Of Bronchial HyperresponsiveNational Heart, Lung, And Blood Institute1995
  • Humoral &Cell-Mediated Immunity In Development Of Bronchial HyperresponsivenessNational Heart, Lung, And Blood Institute1992–1994
  • Activation &Transformation Of Human B Cells By EB VirusNational Institute Of Allergy And Infectious Diseases1990–1992
  • Humoral And Cell-Mediated Immunity Indevelopment Of Bronchial HyperresponsivenessNational Heart, Lung, And Blood Institute1991
  • Ionic,Biochemical,Genetic Basis For Cyclosporin ActivityNational Institute Of Allergy And Infectious Diseases1989–1991

Dr. Erwin Gelfand, Dr. Erwin Gelfand, MD, Dr. E Gelfand, Dr. Erwin W Gelfand